Related Experiment Videos

[Characterization of Neisseria meningitidis isolated fron systemic infections. Chile, 1992-1993]

L Castillo1, A Maldonado, J García

  • 1Departamento Laboratorios de Salud, Ministerio de Salud, Santiago de Chile.

Revista Medica De Chile
|July 1, 1994
PubMed
Abstract

Insights

Meningococcal disease surveillance in Chile identified Neisseria meningitidis serogroup B as the dominant cause in 1992-1993. Emergence of reduced susceptibility to penicillin and rifampicin in some strains is a growing concern.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Public Health Surveillance

Background:

  • Mandatory reporting of Neisseria meningitidis systemic infections in Chile.
  • Bacterial strains are sent to the Instituto de Salud Pública de Chile (ISP) for laboratory analysis.

Purpose of the Study:

  • To characterize Neisseria meningitidis strains isolated from systemic infections in Chile during 1992 and 1993.
  • To assess serogroup, serotype, subtype, and antimicrobial susceptibility patterns.

Main Methods:

  • Serological characterization (serogroup, serotype, subtype) of N. meningitidis strains.
  • Antimicrobial susceptibility testing including penicillin, chloramphenicol, ceftriaxone, and rifampicin.
  • Analysis of strains received at the ISP Reference Laboratory.

Main Results:

  • 628 N. meningitidis strains were confirmed between 1992-1993.
  • Serogroup B was predominant, causing over 91% of infections.
  • Serotypes B:15:P1.3 and B:NT:P1.3 were most common; initial susceptibility to key antibiotics, but moderate penicillin/rifampicin resistance emerged in 1993.

Conclusions:

  • Increasing isolation of non-typable (NT) strains necessitates molecular identification methods.
  • The emergence of penicillin-resistant Neisseria meningitidis strains in Chile is a significant public health concern.

Related Concept Videos